143 related articles for article (PubMed ID: 18952634)
21. Effect of alcohol-induced septal ablation on left atrial volume and ejection fraction assessed by real time three-dimensional transthoracic echocardiography in patients with hypertrophic cardiomyopathy.
Hage FG; Karakus G; Luke WD; Suwanjutah T; Burri MV; Nanda NC; Aqel RA
Echocardiography; 2008 Aug; 25(7):784-9. PubMed ID: 18754938
[TBL] [Abstract][Full Text] [Related]
22. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Nielsen CD; Fernandes V; Spencer WH
Am Heart Hosp J; 2003; 1(1):83-90. PubMed ID: 15785181
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
Noble S; Sigwart U
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
[TBL] [Abstract][Full Text] [Related]
24. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.
Soliman OI; Knaapen P; Geleijnse ML; Dijkmans PA; Anwar AM; Nemes A; Michels M; Vletter WB; Lammertsma AA; ten Cate FJ
Heart; 2007 Oct; 93(10):1204-12. PubMed ID: 17488767
[TBL] [Abstract][Full Text] [Related]
25. Transthoracic echocardiographic evaluation of coronary flow reserve in patients with hypertrophic cardiomyopathy.
Kim HK; Kim YJ; Sohn DW; Park YB; Choi YS
Int J Cardiol; 2004 Apr; 94(2-3):167-71. PubMed ID: 15093975
[TBL] [Abstract][Full Text] [Related]
26. Impact of alcohol septal ablation on left anterior descending coronary artery blood flow in hypertrophic obstructive cardiomyopathy.
van Dockum WG; Knaapen P; Hofman MB; Kuijer JP; ten Cate FJ; ten Berg JM; Beek AM; Twisk JW; van Rossum AC
Int J Cardiovasc Imaging; 2009 Jun; 25(5):511-8. PubMed ID: 19234870
[TBL] [Abstract][Full Text] [Related]
27. Coronary flow dynamics and reserve assessed by transesophageal echocardiography in obstructive hypertrophic cardiomyopathy.
Memmola C; Iliceto S; Napoli VF; Cavallari D; Santoro G; Rizzon P
Am J Cardiol; 1994 Dec; 74(11):1147-51. PubMed ID: 7977076
[TBL] [Abstract][Full Text] [Related]
28. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
[TBL] [Abstract][Full Text] [Related]
29. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and echocardiographic follow-up of patients with hypertrophic obstructive cardiomyopathy treated by percutaneous septal ablation].
Delgado V; Sitges M; Andrea R; Rivera S; Masotti M; Francino A; Azqueta M; Paré C; Betriu A
Rev Esp Cardiol; 2006 Nov; 59(11):1123-30. PubMed ID: 17144987
[TBL] [Abstract][Full Text] [Related]
31. [Left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy treated with percutaneous alcohol septal ablation: an echocardiographic study].
Rivera S; Sitges M; Azqueta M; Marigliano A; Velamazán M; Miranda-Guardiola F; Betriu A; Paré C
Rev Esp Cardiol; 2003 Dec; 56(12):1174-81. PubMed ID: 14670269
[TBL] [Abstract][Full Text] [Related]
32. Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases.
Kambiré Y; Millogo GRC; Dauphin C; Lusson JR
Pan Afr Med J; 2017; 27():196. PubMed ID: 28904721
[TBL] [Abstract][Full Text] [Related]
33. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
[TBL] [Abstract][Full Text] [Related]
34. Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy.
Carasso S; Woo A; Yang H; Schwartz L; Vannan MA; Jamorski M; Linghorne M; Wigle ED; Rakowski H
J Am Soc Echocardiogr; 2008 May; 21(5):493-9. PubMed ID: 17961980
[TBL] [Abstract][Full Text] [Related]
35. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
36. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
Veselka J; Procházková S; Duchonová R; Bolomová-Homolová I; Pálenícková J; Tesar D; Cervinka P; Honek T
Catheter Cardiovasc Interv; 2004 Oct; 63(2):231-5. PubMed ID: 15390343
[TBL] [Abstract][Full Text] [Related]
37. Transient impairment of coronary flow reserve in tako-tsubo cardiomyopathy is related to left ventricular systolic parameters.
Meimoun P; Malaquin D; Benali T; Boulanger J; Zemir H; Tribouilloy C
Eur J Echocardiogr; 2009 Mar; 10(2):265-70. PubMed ID: 18755700
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy.
Monakier D; Woo A; Puri T; Schwartz L; Ross J; Jamorski M; Yang H; Liu Z; Vannan M; Wigle ED; Rakowski H
Am J Cardiol; 2004 Dec; 94(12):1515-22. PubMed ID: 15589007
[TBL] [Abstract][Full Text] [Related]
39. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
[TBL] [Abstract][Full Text] [Related]
40. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
Timmer SA; Knaapen P; Germans T; Dijkmans PA; Lubberink M; Ten Berg JM; Ten Cate FJ; Rüssel IK; Götte MJ; Lammertsma AA; van Rossum AC
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H129-37. PubMed ID: 21490327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
